| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.16e-11 | 11 | 111 | 6 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.22e-09 | 37 | 111 | 7 | GO:0016891 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | ERVK-6 XRN2 DIS3L ERVK-7 ERVK-10 RNASEL NYNRIN ERVK-8 PRORP ERVK-11 | 4.42e-09 | 136 | 111 | 10 | GO:0004540 |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6.06e-09 | 46 | 111 | 7 | GO:0016893 | |
| GeneOntologyMolecularFunction | nuclease activity | ERVK-6 XRN2 ERCC5 DIS3L ERVK-7 ERVK-10 RNASEL NYNRIN ERVK-8 PRORP TDP1 ERVK-11 | 6.21e-09 | 231 | 111 | 12 | GO:0004518 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.32e-09 | 14 | 111 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.33e-08 | 79 | 111 | 8 | GO:0004521 | |
| GeneOntologyMolecularFunction | endonuclease activity | ERVK-6 ERCC5 ERVK-7 ERVK-10 RNASEL NYNRIN ERVK-8 PRORP ERVK-11 | 6.78e-08 | 136 | 111 | 9 | GO:0004519 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 9.19e-08 | 21 | 111 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.10e-06 | 38 | 111 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 XRN2 DIS3L ERVK-7 ERVK-10 RNASEL NYNRIN ERVK-8 MEPCE PRORP ERVK-11 | 2.10e-05 | 417 | 111 | 11 | GO:0140098 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 5.19e-05 | 37 | 111 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 5.77e-05 | 38 | 111 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 XRN2 ERCC5 DIS3L ERVK-7 ERVK-10 RNASEL NYNRIN ERVK-8 MEPCE PRORP TDP1 ERVK-11 | 6.08e-05 | 645 | 111 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 XRN2 ERCC5 DIS3L ERVK-7 ERVK-10 PNPLA5 RNASEL NYNRIN ERVK-8 PRORP TDP1 ERVK-11 ABHD12 | 1.54e-04 | 807 | 111 | 14 | GO:0016788 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 2.07e-04 | 152 | 111 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 4.02e-04 | 172 | 111 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.58e-04 | 262 | 111 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | 7SK snRNA binding | 1.07e-03 | 9 | 111 | 2 | GO:0097322 | |
| GeneOntologyMolecularFunction | methylated histone binding | 1.35e-03 | 86 | 111 | 4 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 1.47e-03 | 88 | 111 | 4 | GO:0140034 | |
| GeneOntologyBiologicalProcess | DNA integration | 4.15e-11 | 13 | 114 | 6 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.54e-07 | 48 | 114 | 6 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 6.67e-06 | 83 | 114 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA replication | 5.96e-05 | 312 | 114 | 9 | GO:0006260 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 6.00e-05 | 178 | 114 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 XRN2 ERCC5 ATR ERVK-7 ERVK-10 SIRT7 GTF2H3 NYNRIN ERVK-8 SMARCE1 TDP1 ERVK-11 | 6.08e-05 | 648 | 114 | 13 | GO:0006281 |
| GeneOntologyBiologicalProcess | positive regulation of sodium ion transport | 8.42e-05 | 42 | 114 | 4 | GO:0010765 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of exogenous peptide antigen via MHC class I | 1.26e-04 | 18 | 114 | 3 | GO:0042590 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.07e-04 | 85 | 115 | 5 | GO:0000118 | |
| Domain | FAM209 | 3.50e-05 | 2 | 111 | 2 | PF15206 | |
| Domain | FAM209 | 3.50e-05 | 2 | 111 | 2 | IPR027943 | |
| Domain | FA58C | 2.51e-04 | 21 | 111 | 3 | SM00231 | |
| Domain | FA58C_3 | 2.51e-04 | 21 | 111 | 3 | PS50022 | |
| Domain | FA58C_1 | 2.51e-04 | 21 | 111 | 3 | PS01285 | |
| Domain | FA58C_2 | 2.51e-04 | 21 | 111 | 3 | PS01286 | |
| Domain | INTEGRASE | 3.46e-04 | 5 | 111 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 3.46e-04 | 5 | 111 | 2 | IPR001584 | |
| Domain | F5_F8_type_C | 3.78e-04 | 24 | 111 | 3 | PF00754 | |
| Domain | FA58C | 3.78e-04 | 24 | 111 | 3 | IPR000421 | |
| Domain | Laminin_G | 3.92e-04 | 58 | 111 | 4 | IPR001791 | |
| Domain | TLV_coat | 7.21e-04 | 7 | 111 | 2 | PF00429 | |
| Domain | - | 8.44e-04 | 333 | 111 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 8.77e-04 | 335 | 111 | 8 | IPR015943 | |
| Domain | Chromodomain-like | 8.94e-04 | 32 | 111 | 3 | IPR016197 | |
| Domain | - | 9.38e-04 | 73 | 111 | 4 | 2.60.120.260 | |
| Domain | TLV/ENV_coat_polyprotein | 9.57e-04 | 8 | 111 | 2 | IPR018154 | |
| Domain | Chromo/shadow_dom | 9.79e-04 | 33 | 111 | 3 | IPR000953 | |
| Domain | CHROMO | 9.79e-04 | 33 | 111 | 3 | SM00298 | |
| Domain | WD40 | 1.11e-03 | 268 | 111 | 7 | SM00320 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.47e-08 | 94 | 118 | 7 | 21542922 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.52e-07 | 4 | 118 | 3 | 10469592 | |
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 23085571 | ||
| Pubmed | Genetic modifiers of muscular dystrophy: implications for therapy. | 3.15e-06 | 9 | 118 | 3 | 16916601 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18826608 | ||
| Pubmed | Inflammation-related gene variants as risk factors for pancreatic cancer. | 1.14e-05 | 2 | 118 | 2 | 21467233 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23555306 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21652631 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22693453 | ||
| Pubmed | Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice. | 1.14e-05 | 2 | 118 | 2 | 26355035 | |
| Pubmed | 1.40e-05 | 43 | 118 | 4 | 25130324 | ||
| Pubmed | 2.17e-05 | 339 | 118 | 8 | 30415952 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 15998811 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 9971820 | ||
| Pubmed | Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. | 3.42e-05 | 3 | 118 | 2 | 16684813 | |
| Pubmed | Supramammillary glutamate neurons are a key node of the arousal system. | 3.42e-05 | 3 | 118 | 2 | 29123082 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 17350656 | ||
| Pubmed | nNOS-Expressing Neurons in the Ventral Tegmental Area and Substantia Nigra Pars Compacta. | 3.42e-05 | 3 | 118 | 2 | 30456293 | |
| Pubmed | 3.80e-05 | 268 | 118 | 7 | 33640491 | ||
| Pubmed | 4.90e-05 | 493 | 118 | 9 | 15368895 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | RANBP1 ATR CD109 MAP7 ITGA7 ECE1 IGSF10 MGAT5 LNPEP CSPG4 SMARCE1 IL1RAP ABHD12 DCBLD2 | 5.87e-05 | 1201 | 118 | 14 | 35696571 |
| Pubmed | Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. | 6.82e-05 | 4 | 118 | 2 | 9427295 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 24957906 | ||
| Pubmed | A disinhibitory nigra-parafascicular pathway amplifies seizure in temporal lobe epilepsy. | 6.82e-05 | 4 | 118 | 2 | 32066723 | |
| Pubmed | Differential depletion of GluN2A induces heterogeneous schizophrenia-related phenotypes in mice. | 6.82e-05 | 4 | 118 | 2 | 38471394 | |
| Pubmed | Hierarchical neural architecture underlying thirst regulation. | 6.82e-05 | 4 | 118 | 2 | 29489747 | |
| Pubmed | NMDA Receptors in the Lateral Preoptic Hypothalamus Are Essential for Sustaining NREM and REM Sleep. | 6.82e-05 | 4 | 118 | 2 | 35649726 | |
| Pubmed | Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy. | 6.82e-05 | 4 | 118 | 2 | 24631023 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 7983737 | ||
| Pubmed | Phenotyping of nNOS neurons in the postnatal and adult female mouse hypothalamus. | 6.82e-05 | 4 | 118 | 2 | 28577305 | |
| Pubmed | 1.01e-04 | 217 | 118 | 6 | 34048709 | ||
| Pubmed | KDM4C CD109 ECE1 C8orf34 WDR59 THBS2 KCNB1 FAM209B CNTNAP2 PKP2 ECI2 | 1.07e-04 | 814 | 118 | 11 | 23251661 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.13e-04 | 5 | 118 | 2 | 12629516 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.13e-04 | 5 | 118 | 2 | 11401426 | |
| Pubmed | GABA and glutamate neurons in the VTA regulate sleep and wakefulness. | 1.13e-04 | 5 | 118 | 2 | 30559475 | |
| Pubmed | FAM209 associates with DPY19L2, and is required for sperm acrosome biogenesis and fertility in mice. | 1.13e-04 | 5 | 118 | 2 | 34471926 | |
| Pubmed | Structured Dendritic Inhibition Supports Branch-Selective Integration in CA1 Pyramidal Cells. | 1.13e-04 | 5 | 118 | 2 | 26898780 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 26440893 | ||
| Pubmed | Synaptic control of spinal GRPR+ neurons by local and long-range inhibitory inputs. | 1.13e-04 | 5 | 118 | 2 | 31806757 | |
| Pubmed | 1.13e-04 | 5 | 118 | 2 | 33495326 | ||
| Pubmed | The NYN domains: novel predicted RNAses with a PIN domain-like fold. | 1.13e-04 | 5 | 118 | 2 | 17114934 | |
| Pubmed | PPIL6 LAMA2 CHRNB3 IGSF10 SAMD9L STARD9 PKD1 SHOC1 ABCG2 TDP1 | 1.20e-04 | 686 | 118 | 10 | 29987050 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.55e-04 | 148 | 118 | 5 | 32538781 | |
| Pubmed | 1.63e-04 | 453 | 118 | 8 | 29656893 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 22318730 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 11054877 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 18611855 | ||
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 1.70e-04 | 6 | 118 | 2 | 22925892 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 38573307 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 15314177 | ||
| Pubmed | IL-17a promotes sociability in mouse models of neurodevelopmental disorders. | 1.70e-04 | 6 | 118 | 2 | 31853066 | |
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 18583959 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 28431135 | ||
| Pubmed | 1.70e-04 | 6 | 118 | 2 | 18281698 | ||
| Pubmed | 2.04e-04 | 157 | 118 | 5 | 30186101 | ||
| Pubmed | 2.26e-04 | 604 | 118 | 9 | 38803224 | ||
| Pubmed | Calcitonin receptor signaling in the medial preoptic area enables risk-taking maternal care. | 2.37e-04 | 7 | 118 | 2 | 34077719 | |
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 2.37e-04 | 7 | 118 | 2 | 9004048 | |
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 22615490 | ||
| Pubmed | Neural basis for regulation of vasopressin secretion by anticipated disturbances in osmolality. | 2.37e-04 | 7 | 118 | 2 | 34585668 | |
| Pubmed | Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. | 2.37e-04 | 7 | 118 | 2 | 17475492 | |
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 8950511 | ||
| Pubmed | 2.37e-04 | 7 | 118 | 2 | 29914853 | ||
| Pubmed | 2.54e-04 | 257 | 118 | 6 | 16335952 | ||
| Pubmed | 2.72e-04 | 37 | 118 | 3 | 22797727 | ||
| Pubmed | Identification and characterization of three new components of the mSin3A corepressor complex. | 3.15e-04 | 8 | 118 | 2 | 12724404 | |
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 11115849 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 17360663 | ||
| Pubmed | Recognition and specificity determinants of the human cbx chromodomains. | 3.15e-04 | 8 | 118 | 2 | 21047797 | |
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 8652557 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 18483487 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 33504453 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 18606955 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 10757814 | ||
| Pubmed | 3.15e-04 | 8 | 118 | 2 | 24316072 | ||
| Pubmed | 3.86e-04 | 650 | 118 | 9 | 38777146 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 4.03e-04 | 182 | 118 | 5 | 32239614 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | XRN2 ARID4B CWC25 JMJD1C CKB CCNT1 CBX5 SIMC1 SMARCE1 TASOR CBX2 | 4.15e-04 | 954 | 118 | 11 | 36373674 |
| Pubmed | 4.87e-04 | 45 | 118 | 3 | 25979088 | ||
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 20153263 | ||
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 15696166 | ||
| Pubmed | TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. | 5.05e-04 | 10 | 118 | 2 | 21490601 | |
| Pubmed | NTS Prlh overcomes orexigenic stimuli and ameliorates dietary and genetic forms of obesity. | 5.05e-04 | 10 | 118 | 2 | 34462445 | |
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 17478428 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 5.05e-04 | 10 | 118 | 2 | 18590826 | |
| Pubmed | 5.05e-04 | 10 | 118 | 2 | 11784026 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.16e-04 | 410 | 118 | 7 | 26949251 | |
| Pubmed | 5.54e-04 | 47 | 118 | 3 | 31235642 | ||
| Pubmed | Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. | 6.15e-04 | 11 | 118 | 2 | 15739233 | |
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 20471949 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 23748610 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 8581564 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 21989910 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 24367103 | ||
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 25189618 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 6.15e-04 | 11 | 118 | 2 | 25731772 | |
| Pubmed | 6.15e-04 | 11 | 118 | 2 | 10082552 | ||
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 11381080 | ||
| Pubmed | 7.37e-04 | 12 | 118 | 2 | 14557543 | ||
| Pubmed | Expression of laminin receptors in schwann cell differentiation: evidence for distinct roles. | 7.37e-04 | 12 | 118 | 2 | 12843252 | |
| Cytoband | 15q24.2 | 7.77e-05 | 32 | 118 | 3 | 15q24.2 | |
| Cytoband | 8p11.2 | 5.84e-04 | 14 | 118 | 2 | 8p11.2 | |
| Cytoband | 20q13.31 | 7.68e-04 | 16 | 118 | 2 | 20q13.31 | |
| GeneFamily | WD repeat domain containing | 3.24e-04 | 262 | 64 | 6 | 362 | |
| GeneFamily | Chromobox family | 3.41e-04 | 8 | 64 | 2 | 976 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 2.32e-06 | 199 | 112 | 8 | M5607 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-08 | 184 | 113 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-07 | 195 | 113 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 160 | 113 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-06 | 160 | 113 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 176 | 113 | 6 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-06 | 176 | 113 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-06 | 182 | 113 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 8.57e-06 | 188 | 113 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 189 | 113 | 6 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 189 | 113 | 6 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 189 | 113 | 6 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-06 | 189 | 113 | 6 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-06 | 190 | 113 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 9.66e-06 | 192 | 113 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.66e-06 | 192 | 113 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 9.66e-06 | 192 | 113 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.95e-06 | 193 | 113 | 6 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.95e-06 | 193 | 113 | 6 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 194 | 113 | 6 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.02e-05 | 194 | 113 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 194 | 113 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-early_MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-05 | 195 | 113 | 6 | 9b4f217325afb2efb9c65f298ac87649cb1e1af9 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 1.09e-05 | 196 | 113 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.12e-05 | 197 | 113 | 6 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | Sepsis-Int-URO-Others-RBC|Int-URO / Disease, condition lineage and cell class | 1.15e-05 | 198 | 113 | 6 | 29203aaa5c1844f72289e03f585cd5e7fc498a9a | |
| ToppCell | Sepsis-Int-URO-Others|Int-URO / Disease, condition lineage and cell class | 1.15e-05 | 198 | 113 | 6 | 67f721ea8e60042317ba12efd584f56b07cfb29d | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-05 | 198 | 113 | 6 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.18e-05 | 199 | 113 | 6 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 6.74e-05 | 167 | 113 | 5 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 172 | 113 | 5 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.75e-05 | 172 | 113 | 5 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 175 | 113 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.40e-05 | 175 | 113 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.63e-05 | 176 | 113 | 5 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.10e-05 | 178 | 113 | 5 | 2120bd3e099b0b271bf079db9827a2f3eee2f909 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-05 | 178 | 113 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.35e-05 | 179 | 113 | 5 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-04 | 182 | 113 | 5 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 1.01e-04 | 182 | 113 | 5 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 1.01e-04 | 182 | 113 | 5 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 182 | 113 | 5 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 182 | 113 | 5 | 6e7dac78dc030f74e546b9f6db07556e9bb13ac2 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 182 | 113 | 5 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 182 | 113 | 5 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 182 | 113 | 5 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | cellseq-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 182 | 113 | 5 | cd972d30519db706477c6b0c901165b81b74abed | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 182 | 113 | 5 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 1.04e-04 | 183 | 113 | 5 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 113 | 5 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 183 | 113 | 5 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 1.04e-04 | 183 | 113 | 5 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 183 | 113 | 5 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 184 | 113 | 5 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 184 | 113 | 5 | a60802e11dcc5f932811260b08a95a32f60f6b19 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-04 | 184 | 113 | 5 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-04 | 184 | 113 | 5 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 184 | 113 | 5 | 39c230d32e4259bc784e0edfd9e2884c96898564 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-04 | 184 | 113 | 5 | 2a2fb691cc9414ef5b06c26239d2da03d6d7e5c2 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-04 | 184 | 113 | 5 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-04 | 184 | 113 | 5 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-04 | 184 | 113 | 5 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-04 | 184 | 113 | 5 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 185 | 113 | 5 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.09e-04 | 185 | 113 | 5 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.09e-04 | 185 | 113 | 5 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 1.09e-04 | 185 | 113 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.12e-04 | 186 | 113 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-04 | 186 | 113 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 186 | 113 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.15e-04 | 187 | 113 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 188 | 113 | 5 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | 21-Trachea-Epithelial-Multiciliated_cell|Trachea / Age, Tissue, Lineage and Cell class | 1.18e-04 | 188 | 113 | 5 | 803bf76a85b3033d2a04b08dd2c03ce9c15529ba | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 189 | 113 | 5 | e127e3be626bc513e151d41812f0b7adb89d5da6 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 189 | 113 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-04 | 189 | 113 | 5 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 189 | 113 | 5 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 1.21e-04 | 189 | 113 | 5 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | COVID-19_Severe-HSPC|COVID-19_Severe / disease group, cell group and cell class | 1.21e-04 | 189 | 113 | 5 | 96015439971e2e5b8d6294ca5a6b873c7774e925 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 189 | 113 | 5 | ff637ae0afdb1fdc67451be7e1e4fe575fbcfff4 | |
| ToppCell | hematopoetic_progenitors-CD34+_HSC|World / Lineage and Cell class | 1.21e-04 | 189 | 113 | 5 | 51ff31c9cf5eff98ad01c0455dc4ae4908713575 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 189 | 113 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 189 | 113 | 5 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-04 | 190 | 113 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | control-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.27e-04 | 191 | 113 | 5 | db1b3cd07d7d190155b2d14e82e1d124975fbd0b | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 191 | 113 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 113 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 113 | 5 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 191 | 113 | 5 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-04 | 192 | 113 | 5 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.30e-04 | 192 | 113 | 5 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.30e-04 | 192 | 113 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.30e-04 | 192 | 113 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 193 | 113 | 5 | 5182284dfa7c94027e94172e08f78c86b95d63f4 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.33e-04 | 193 | 113 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.33e-04 | 193 | 113 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 113 | 5 | 8be24713f8ba2545b7647d1994e9e993623ddaa3 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.33e-04 | 193 | 113 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 113 | 5 | 19dfc4a2c91fcea4f5991e7c44df46faeecb06b8 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 193 | 113 | 5 | 351e0acd411a9eb0dbc0e358d0d1e3759753fa40 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-04 | 193 | 113 | 5 | 4f7bab0115469c855160636d168bd6e5d4e2dd2f | |
| Drug | Beta-sistosterol [83-46-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.96e-07 | 196 | 113 | 9 | 4154_UP | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 8.14e-06 | 11 | 110 | 3 | DOID:9279 (implicated_via_orthology) | |
| Disease | Muscular dystrophy congenital, merosin negative | 1.38e-05 | 2 | 110 | 2 | C1263858 | |
| Disease | birdshot chorioretinopathy | 1.38e-05 | 2 | 110 | 2 | MONDO_0011599 | |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 1.37e-04 | 5 | 110 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Congenital muscular dystrophy (disorder) | 2.05e-04 | 6 | 110 | 2 | C0699743 | |
| Disease | Morphine Abuse | 2.86e-04 | 7 | 110 | 2 | C0600272 | |
| Disease | Morphine Dependence | 2.86e-04 | 7 | 110 | 2 | C0026552 | |
| Disease | epilepsy (implicated_via_orthology) | 3.71e-04 | 163 | 110 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 4.49e-04 | 261 | 110 | 6 | C0004352 | |
| Disease | lean body mass | 5.59e-04 | 379 | 110 | 7 | EFO_0004995 | |
| Disease | Semantic-Pragmatic Disorder | 7.41e-04 | 11 | 110 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 7.41e-04 | 11 | 110 | 2 | C0751257 | |
| Disease | Language Delay | 7.41e-04 | 11 | 110 | 2 | C0023012 | |
| Disease | Language Development Disorders | 7.41e-04 | 11 | 110 | 2 | C0023014 | |
| Disease | Speech Delay | 7.41e-04 | 11 | 110 | 2 | C0241210 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.36e-04 | 195 | 110 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy | 8.87e-04 | 12 | 110 | 2 | cv:C0699743 | |
| Disease | Heschl's gyrus morphology measurement | 1.03e-03 | 53 | 110 | 3 | EFO_0005852 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 1.15e-03 | 122 | 110 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | glycerol-3-phosphate measurement | 1.40e-03 | 15 | 110 | 2 | EFO_0010488 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 2.26e-03 | 19 | 110 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 2.26e-03 | 19 | 110 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | calcium measurement | 2.47e-03 | 628 | 110 | 8 | EFO_0004838 | |
| Disease | alpha-tocopherol measurement | 2.50e-03 | 20 | 110 | 2 | EFO_0007898 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.56e-03 | 152 | 110 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | leucine measurement | 2.59e-03 | 73 | 110 | 3 | EFO_0009770 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 3.60e-03 | 24 | 110 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | longitudinal BMI measurement | 3.60e-03 | 82 | 110 | 3 | EFO_0005937 | |
| Disease | eosinophil count | TRERF1 ATR KDM4C SYT17 PPIL6 ECE1 WDR59 CKB MGAT5 CFAP92 SMARCE1 PCNX1 FUCA1 | 3.63e-03 | 1488 | 110 | 13 | EFO_0004842 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVWSSIQGQWPKKTL | 926 | Q4LE39 | |
| QNLPEHTQGWLGSKW | 46 | Q5JX71 | |
| LKQEWTDHKLRWNPD | 81 | Q05901 | |
| VKKQGPNLHNWSGDW | 41 | Q8IYS0 | |
| QPWGLVKSLIEKNSW | 461 | Q8IYS0 | |
| NTWHGRPEEKWNPQT | 4671 | Q9NR09 | |
| SWHPQTLRNVEKVWK | 11 | Q9NXE8 | |
| HLWKNKGLWVPEGQR | 1706 | Q6UVK1 | |
| WKGFSEEHNTWEPEK | 41 | P45973 | |
| GVWFKHPENNRTWSN | 116 | P30988 | |
| KQGIDLSPWGLWKNH | 616 | Q9UNQ0 | |
| SVEHPKWNWRTKPQS | 206 | Q49A92 | |
| QTIPAGWKSQLHKWF | 226 | B6SEH9 | |
| KHSQQIGDSWEWRPS | 21 | Q9H0Y0 | |
| KWSNWEIPVSTDGKH | 206 | O60563 | |
| KTVKPWHEGDKAWVS | 151 | Q9ULG3 | |
| AKSGKHSDPVWQVKW | 426 | Q9UI46 | |
| ESENDWWVSKHIKKP | 126 | Q92747 | |
| KPNAGSDRAWVWNTH | 111 | P43487 | |
| LWGHTIQVDWADPEK | 211 | Q8TBY0 | |
| NSLKPEEGLEVWKNW | 471 | Q2TAL8 | |
| WIKDSQTHQWRLGEP | 621 | Q2M385 | |
| WHTVPAVWWKNAQGK | 141 | Q8N2K0 | |
| GQWKHSRVENPLWNK | 876 | M0R2J8 | |
| QKPKQKHNRWSWGGS | 151 | Q14244 | |
| KAHLLNIPSWNWKEG | 531 | Q12791 | |
| QPWNSWTGRKKHELK | 346 | Q8NCT3 | |
| QKNIHLWTPTDGGSW | 236 | Q9BQ67 | |
| WQPVQWHSKVRQKSE | 226 | O14920 | |
| LSLTKWVHLNWGDEG | 581 | Q7L2J0 | |
| YAQSKGHKTPWGKWN | 391 | Q09328 | |
| WPDARGIWHNDNKTF | 211 | P12277 | |
| SRNEVWWTIDGKKPD | 276 | Q9NPH3 | |
| WRPNNNLSKEKTEWH | 1276 | Q15652 | |
| QTIPAGWKSQLHKWF | 226 | B6SEH8 | |
| WLHKEAQKEGWSKAA | 81 | P43897 | |
| LKAGRNSWKDWSPQE | 2276 | Q96RV3 | |
| DTAIGQWLRWDKNPK | 26 | Q6PCE3 | |
| QNLPEHTQGWLGSKW | 46 | Q5JX69 | |
| WNWNSKDVGPHRDLV | 151 | P04066 | |
| TGKKNSPHEGKLIWW | 801 | P63132 | |
| SPHEGKLIWWKDNKN | 806 | P63132 | |
| ESWAKPLIHLWQTKS | 611 | Q9H3R0 | |
| PGHLLAWDFVKENWN | 936 | Q9UIQ6 | |
| TPIHWKQAWEKLDAD | 251 | Q8N9Z9 | |
| RHPITNAIDGKNTWW | 96 | P24043 | |
| KNTWWQSPSIKNGIE | 106 | P24043 | |
| WDNHYGTQIPKEEWK | 1586 | P00451 | |
| SENKWSQEKHSPWEG | 331 | Q2M2Z5 | |
| QKWAHEVWDIVDIKP | 106 | Q8IXY8 | |
| TGKKNSPHEGKLIWW | 801 | P63135 | |
| SPHEGKLIWWKDNKN | 806 | P63135 | |
| TGKKNSPHEGKLIWW | 801 | Q9BXR3 | |
| SPHEGKLIWWKDNKN | 806 | Q9BXR3 | |
| WNTHVWKGTNGTPTK | 716 | P29475 | |
| VKNHNPDKVWWAKNS | 41 | Q8N5W8 | |
| KWLWSKGDVHQALIV | 1961 | Q13535 | |
| WLKGHQKSNGEFWDP | 1016 | Q6YHK3 | |
| HLKWLSDWIQEKPDV | 226 | Q6WRI0 | |
| EEWLLSTNGTWHKLG | 781 | Q93033 | |
| VAEWQLHGHPSKWIN | 911 | Q93033 | |
| DKVQDNHLSPNKWKW | 476 | Q14721 | |
| VKWRGWSSKHNSWEP | 31 | Q14781 | |
| LWIPWMKSKEGHLQN | 861 | Q4L180 | |
| WVAKKIWESFPHQAL | 691 | Q8TF46 | |
| TWNGQKLLWLPEKSD | 116 | Q8N1D5 | |
| AHLIEWKGWSAQPAG | 111 | Q96AQ9 | |
| GKKWWTQAQAHDLVI | 231 | O14791 | |
| KHIGKTWAQLEWVPE | 536 | Q99062 | |
| TLKHIQAPWWKKLGE | 556 | Q15051 | |
| GSPYTWWVGKANEKH | 701 | Q9UHC6 | |
| NIMWPHEIANGKWLL | 906 | Q13683 | |
| AKWDAWNALGSLPKE | 91 | O75521 | |
| WTDHTGQENSWKPKK | 316 | Q96PD2 | |
| DKDGNLRPWWKNSSV | 621 | P42892 | |
| APWKRKDQSQVTWHE | 416 | Q6IA86 | |
| HWTKTIPNHKEQEWD | 96 | Q9Y6Q1 | |
| AQEEWTTGAWKNPHV | 186 | Q8TAC9 | |
| VSWNTIPWKLSNGHL | 821 | Q9P232 | |
| QEQWETKWKTVQPHT | 231 | Q6PJW8 | |
| KIRVWHDNKGLSPAW | 3181 | P98161 | |
| LLKQKPDWQWDQEHE | 1121 | Q9P2P1 | |
| WDQVKASNPDLKLWE | 81 | Q969G3 | |
| GHWWKALIPSSQNEV | 306 | Q9BSW7 | |
| AKAWVQKQQWLPEDS | 191 | Q6PIV7 | |
| SKGPNVKNWNAWTAL | 816 | Q9Y4C2 | |
| LWHSGDVWKKNEVKD | 1506 | Q8IVG5 | |
| WKGGLSLNWKVPHVQ | 286 | Q7Z6Z6 | |
| KFSEWWHEAQKNPKI | 891 | P28715 | |
| KAHPIWKWQLGGSAI | 881 | Q1XH10 | |
| WKPQSSHWGAALKDL | 336 | Q05823 | |
| QLHPANAKTVEWDWK | 536 | Q8NDZ2 | |
| QAWVDKWTKEHVPRE | 1211 | Q96ST3 | |
| PLHWNFKKNIWEQEN | 1291 | Q5VXU9 | |
| VNLQWTPKDDWAALK | 296 | Q9NRC8 | |
| DHWSQGWAPLRKNSA | 1666 | Q9P2P6 | |
| HSIKTWFESVPGKQW | 321 | O15091 | |
| HKPTDWQKKILIWSG | 61 | Q96A26 | |
| STVPKEGQSVQWWHA | 301 | Q9NRX5 | |
| LSTPEGKWQWKVHCK | 1356 | Q9UK61 | |
| KWSPKQVVDWTRGLD | 6 | G9CGD6 | |
| KWSPKQVVDWTRGLD | 6 | Q6P9H4 | |
| HADWHQKTQGIWLSP | 286 | Q9NUW8 | |
| SHEWLLWPKAVLQAK | 481 | O15375 | |
| FPDHVELSWWVNGKE | 36 | P01850 | |
| QHGWKEGNEPVEQWK | 46 | Q56A73 | |
| SAPKHEWIGKNSASW | 561 | O15344 | |
| LKPSDWEKSSNGRQW | 781 | Q9H0D6 | |
| TGKKNSPHEGKLIWW | 801 | P10266 | |
| SPHEGKLIWWKDNKN | 806 | P10266 | |
| TGKKNSPHEGKLIWW | 801 | P63133 | |
| SPHEGKLIWWKDNKN | 806 | P63133 | |
| TGKKNSPHEGKLIWW | 801 | Q9UQG0 | |
| SPHEGKLIWWKDNKN | 806 | Q9UQG0 | |
| IISKKPQGDDDHWWQ | 1011 | O15040 | |
| DDPVAWHSKNLKKNW | 56 | Q96BW9 | |
| RQSKWDIGAVQWNPH | 56 | Q6PJI9 | |
| QKKSNLTHWHPVLGW | 351 | Q7Z3V4 | |
| PWKNLKQDETGHWIS | 636 | P86452 | |
| WGWAPLSHGSKEKAL | 71 | O95201 | |
| HNGDWWKPAQCSKRE | 201 | B2RUY7 | |
| HDKPKITAWEAGWNV | 111 | Q9H598 | |
| WVWPSTQAGHQDKDT | 11 | P35442 | |
| EAEELQHKPLGAWWK | 2476 | Q6ZQQ6 | |
| EEKSNPKGVEWLWHS | 666 | Q99959 | |
| DANPIWWGKQALKES | 16 | Q13889 | |
| HLGEEWQKLIVWKFP | 176 | O43264 | |
| QEKGHWPWAKQQSSL | 1176 | Q70EL1 | |
| AQDTHKATLVWKPWP | 801 | Q96PN7 | |
| EWEKVGKWENHTLSL | 371 | Q12879 |